"Glycine Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances used for their pharmacological actions on glycinergic systems. Glycinergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function.
Descriptor ID |
D018684
|
MeSH Number(s) |
D27.505.519.625.300 D27.505.696.577.300
|
Concept/Terms |
Glycine Agents- Glycine Agents
- Agents, Glycine
- Glycinergic Agent
- Agent, Glycinergic
- Glycinergic Agents
- Agents, Glycinergic
Glycine Effect- Glycine Effect
- Effect, Glycine
- Glycine Effects
- Effects, Glycine
|
Below are MeSH descriptors whose meaning is more general than "Glycine Agents".
Below are MeSH descriptors whose meaning is more specific than "Glycine Agents".
This graph shows the total number of publications written about "Glycine Agents" by people in this website by year, and whether "Glycine Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
1997 | 1 | 0 | 1 |
2009 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glycine Agents" by people in Profiles.
-
Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial. Clin Transl Med. 2021 03; 11(3):e372.
-
Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene. Biol Psychiatry. 2019 10 01; 86(7):523-535.
-
The glycine transport inhibitor sarcosine is an inhibitory glycine receptor agonist. Neuropharmacology. 2009 Oct-Nov; 57(5-6):551-5.
-
Effects of activation of group III metabotropic glutamate receptors on spinal synaptic transmission in a rat model of neuropathic pain. Neuroscience. 2009 Jan 23; 158(2):875-84.
-
Dynamic regulation of glycinergic input to spinal dorsal horn neurones by muscarinic receptor subtypes in rats. J Physiol. 2006 Mar 01; 571(Pt 2):403-13.
-
Developmental changes in the neurotransmitter regulation of correlated spontaneous retinal activity. J Neurosci. 2000 Jan 01; 20(1):351-60.
-
Reduction in thermal hyperalgesia by intrathecal administration of glycine and related compounds. Neurochem Res. 1997 Jan; 22(1):75-9.
-
Reduction in the mechanonociceptive response by intrathecal administration of glycine and related compounds. Neurochem Res. 1996 Oct; 21(10):1221-6.